MedTrace Logo

No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

NCT07115810 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 178

Last updated 2025-08-11

No results posted yet for this study

Summary

The goal of this observational study is to compare the clinical outcomes, molecular features, and immune profiles of patients with synchronous and metachronous distant metastases in Saudi cohort with well characterized differentiated thyroid cancer. The main question it aims to answer is whether timing of metastasis is associated with distinct prognostic or biological behavior in differentiated thyroid cancer from a large Middle Eastern cohort

Conditions

  • Differentiated Thyroid Cancer

Interventions

OTHER

No additional drugs(control Group)

No intervention

Sponsors & Collaborators

  • King Faisal Specialist Hospital & Research Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1988-01-01
Primary Completion
2018-12-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07115810 on ClinicalTrials.gov